Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9538)
All Articles published online
|
Publishing Process of This Article
|
Oct 7, 2016 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lee HW, Ahn SH. Prediction models of hepatocellular carcinoma development in chronic hepatitis B patients. World J Gastroenterol 2016; 22(37): 8314-8321 [PMID: 27729738 DOI: 10.3748/wjg.v22.i37.8314] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v22/i37/8314.htm |
| Number | Citing Articles |
| 1 |
Ke Shi, Ping Li, Qun Zhang, Yi Zhang, Yufei Bi, Xuanwei Zeng, Xianbo Wang. Development of a nomogram to predict the risk of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis on antivirals. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1128062
|
| 2 |
Kwesi Z Tandoh, Osbourne Quaye. Genetic associations in chronic hepatitis B infection: toward developing polygenic risk scores. Future Microbiology 2022; 17(7): 541 doi: 10.2217/fmb-2021-0176
|
| 3 |
Sheng-Jie Shiue, Chao-Ling Cheng, Han-Shiang Shiue, Chun-Nan Chen, Sheng-Wei Cheng, Li-Wei Wu, Ganbolor Jargalsaikhan, Tze-Sian Chan, Hsin-Yi Lin, Ming-Shun Wu. Arthrospira Enhances Seroclearance in Patients with Chronic Hepatitis B Receiving Nucleos(t)ide Analogue through Modulation of TNF-α/IFN-γ Profile. Nutrients 2022; 14(14): 2790 doi: 10.3390/nu14142790
|
| 4 |
Jiang Guo, Xue-Song Gao. Prediction models for development of hepatocellular carcinoma in chronic hepatitis B patients. World Journal of Clinical Cases 2021; 9(14): 3238-3251 doi: 10.12998/wjcc.v9.i14.3238
|
| 5 |
Mira Florea, Teodora Serban, George Razvan Tirpe, Alexandru Tirpe, Monica Lupsor-Platon. Noninvasive Assessment of Hepatitis C Virus Infected Patients Using Vibration-Controlled Transient Elastography. Journal of Clinical Medicine 2021; 10(12): 2575 doi: 10.3390/jcm10122575
|
| 6 |
Yong Zhao, Ling Xiang Kong, Feng Shi Feng, Jiayin Yang, Guo Wei. A simple CD4+ T cells to FIB-4 ratio for evaluating prognosis of BCLC-B hepatocellular carcinoma: a retrospective cohort study. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09433-3
|
| 7 |
Yunfeng Yu, Keke Tong, Gang Hu, Xinyu Yang, Jingyi Wu, Siyang Bai, Rong Yu. Love-hate relationship between hepatitis B virus and type 2 diabetes: a Mendelian randomization study. Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1378311
|
| 8 |
Yuichiro Suzuki, Shinya Maekawa, Nobutoshi Komatsu, Mitsuaki Sato, Akihisa Tatsumi, Mika Miura, Shuya Matsuda, Masaru Muraoka, Natsuko Nakakuki, Hiroko Shindo, Fumitake Amemiya, Shinichi Takano, Mitsuharu Fukasawa, Yasuhiro Nakayama, Tatsuya Yamaguchi, Taisuke Inoue, Tadashi Sato, Minoru Sakamoto, Atsuya Yamashita, Kohji Moriishi, Nobuyuki Enomoto. Hepatitis B virus (HBV)‐infected patients with low hepatitis B surface antigen and high hepatitis B core‐related antigen titers have a high risk of HBV‐related hepatocellular carcinoma. Hepatology Research 2019; 49(1): 51 doi: 10.1111/hepr.13277
|
| 9 |
Coskun Ozer Demirtas, Maurizia Rossana Brunetto. Surveillance for hepatocellular carcinoma in chronic viral hepatitis: Is it time to personalize it?. World Journal of Gastroenterology 2021; 27(33): 5536-5554 doi: 10.3748/wjg.v27.i33.5536
|
| 10 |
Rebecca Dunn, Aaron Wetten, Stuart McPherson, Mhairi C Donnelly. Viral hepatitis in 2021: The challenges remaining and how we should tackle them. World Journal of Gastroenterology 2022; 28(1): 76-95 doi: 10.3748/wjg.v28.i1.76
|
| 11 |
Aftab Ahmed, Farhan Saeed, Muhammad Umair Arshad, Muhammad Afzaal, Ali Imran, Shinawar Waseem Ali, Bushra Niaz, Awais Ahmad, Muhammad Imran. Impact of intermittent fasting on human health: an extended review of metabolic cascades. International Journal of Food Properties 2018; 21(1): 2700 doi: 10.1080/10942912.2018.1560312
|
| 12 |
Patrick Kennedy, Samuel Litwin, Grace Dolman, Antonio Bertoletti, William Mason. Immune Tolerant Chronic Hepatitis B: The Unrecognized Risks. Viruses 2017; 9(5): 96 doi: 10.3390/v9050096
|
| 13 |
Manon Allaire, Jordi Bruix, Marko Korenjak, Sarah Manes, Zorana Maravic, Helen Reeves, Riad Salem, Bruno Sangro, Morris Sherman. What to do about hepatocellular carcinoma: Recommendations for health authorities from the International Liver Cancer Association. JHEP Reports 2022; 4(12): 100578 doi: 10.1016/j.jhepr.2022.100578
|
| 14 |
Lei Chen, Lei Chen, Ying-ying Wang, Li-xiang Zhang, Xiao-gang Xia. A predictive model of bowel resection for incarcerated inguinal hernia based on the systemic immune-inflammation index. Frontiers in Surgery 2022; 9 doi: 10.3389/fsurg.2022.990481
|
| 15 |
Chengxiao Yu, Ci Song, Jun Lv, Meng Zhu, Canqing Yu, Yu Guo, Ling Yang, Yiping Chen, Zhengming Chen, Tao Jiang, Hongxia Ma, Guangfu Jin, Hongbing Shen, Zhibin Hu, Liming Li. Prediction and clinical utility of a liver cancer risk model in Chinese adults: A prospective cohort study of 0.5 million people. International Journal of Cancer 2021; 148(12): 2924 doi: 10.1002/ijc.33487
|
| 16 |
Habiba Kamal, Romina Fornes, Johanna Simin, Per Stål, Ann‐Sofi Duberg, Nele Brusselaers, Soo Aleman. Risk of hepatocellular carcinoma in hepatitis B and D virus co‐infected patients: A systematic review and meta‐analysis of longitudinal studies. Journal of Viral Hepatitis 2021; 28(10): 1431 doi: 10.1111/jvh.13577
|
| 17 |
Hyun-seok Kim, Xian Yu, Jennifer Kramer, Aaron P. Thrift, Pete Richardson, Yao-Chun Hsu, Avegail Flores, Hashem B. El-Serag, Fasiha Kanwal. Comparative performance of risk prediction models for hepatitis B-related hepatocellular carcinoma in the United States. Journal of Hepatology 2022; 76(2): 294 doi: 10.1016/j.jhep.2021.09.009
|
| 18 |
Diren Arda Karaoglu, Meral Uner, Cem Simsek, Ali Osmay Gure, Secil Demirkol-Canli. Transcriptomic Analysis of Hepatitis B Infected Liver for Prediction of Hepatocellular Carcinoma. Biology 2023; 12(2): 188 doi: 10.3390/biology12020188
|
| 19 |
Feng Xia, Qiao Zhang, Guobing Xia, Elijah Ndhlovu, Xiaoping Chen, Zhiyuan Huang, Bixiang Zhang, Peng Zhu. A pathologic scoring system for predicting postoperative prognosis in patients with ruptured hepatocellular carcinoma. Asian Journal of Surgery 2024; doi: 10.1016/j.asjsur.2024.01.139
|
| 20 |
Yiqi Yu, Jingwen Ai, Wenhong Zhang. Current clinical evidence for nucleos(t)ide analogues in patients with HBV-related hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2017; 11(10): 925 doi: 10.1080/17474124.2017.1343665
|
| 21 |
Barbora Lubyova, Jan Hodek, Ales Zabransky, Hana Prouzova, Martin Hubalek, Ivan Hirsch, Jan Weber, Haitao Guo. PRMT5: A novel regulator of Hepatitis B virus replication and an arginine methylase of HBV core. PLOS ONE 2017; 12(10): e0186982 doi: 10.1371/journal.pone.0186982
|
| 22 |
Chansik An, Jong Won Choi, Hyung Soon Lee, Hyunsun Lim, Seok Jong Ryu, Jung Hyun Chang, Hyun Cheol Oh. Prediction of the risk of developing hepatocellular carcinoma in health screening examinees: a Korean cohort study. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08498-w
|
| 23 |
Yinghua Zhang, Chuanfang Wang, Hui Li, Yuanyuan Ding. Decreased liver stiffness by transient elastography indicates lower incidence of hepatocellular carcinoma in patients with chronic hepatitis B. Medicine 2019; 98(3): e13929 doi: 10.1097/MD.0000000000013929
|
| 24 |
Isabelle Beaudry-Bellefeuille, Alison Lane, Simon Chiu, Christopher Oldmeadow, Eduardo Ramos Polo, Shelly J Lane. The Toileting Habit Profile Questionnaire-Revised: Examining Discriminative and Concurrent Validity. Journal of Occupational Therapy, Schools, & Early Intervention 2019; 12(3): 311 doi: 10.1080/19411243.2019.1590756
|
| 25 |
Hye Won Lee, Sang Hoon Ahn, Henry Lik-Yuen Chan. Hepatitis B Core-Related Antigen: From Virology to Clinical Application. Seminars in Liver Disease 2021; 41(02): 182 doi: 10.1055/s-0041-1723088
|
| 26 |
Li Zhao, Qian Yang, Jianbo Liu. Clinical Value Evaluation of microRNA-324-3p and Other Available Biomarkers in Patients With HBV Infection–Related Hepatocellular Carcinoma. Open Forum Infectious Diseases 2021; 8(6) doi: 10.1093/ofid/ofab108
|
| 27 |
Hye Won Lee, Hwiyoung Kim, Taeyun Park, Soo Young Park, Young Eun Chon, Yeon Seok Seo, Jae Seung Lee, Jun Yong park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Seung Up Kim. A machine learning model for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B. Liver International 2023; 43(8): 1813 doi: 10.1111/liv.15597
|
| 28 |
Ahmed Wahid, Mustafa A. Hamzawy, Mohamad M. A. Khalifa, Gamal F. M. Gad, Amany Bekhit, Sayed F. Abdelwahab. RNA protein kinase SNP at −226 C<T is a biomarker for the clearance of HCV among Egyptian patients. Immunological Investigations 2019; 48(3): 211 doi: 10.1080/08820139.2018.1493496
|
| 29 |
An K Le, Hwai-I Yang, Ming-Lun Yeh, Mingjuan Jin, Huy N Trinh, Linda Henry, Anne Liu, Jian Q Zhang, Jiayi Li, Christopher Wong, Clifford Wong, Ramsey Cheung, Ming-Lung Yu, Mindie H Nguyen. Development and Validation of a Risk Score for Liver Cirrhosis Prediction in Untreated and Treated Chronic Hepatitis B. The Journal of Infectious Diseases 2021; 223(1): 139 doi: 10.1093/infdis/jiaa330
|
| 30 |
Ke Shi, Qun Zhang, Yi Zhang, Yufei Bi, Xuanwei Zeng, Xianbo Wang. Association between probiotic therapy and the risk of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis. Frontiers in Cellular and Infection Microbiology 2023; 12 doi: 10.3389/fcimb.2022.1104399
|
| 31 |
Monica Lupsor-Platon, Teodora Serban, Alexandra-Iulia Silion, Alexandru Tirpe, Mira Florea. Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease: A Step Forward for Better Evaluation Using Ultrasound Elastography. Cancers 2020; 12(10): 2778 doi: 10.3390/cancers12102778
|
| 32 |
Anna Kramvis, Kyong-Mi Chang, Maura Dandri, Patrizia Farci, Dieter Glebe, Jianming Hu, Harry L. A. Janssen, Daryl T. Y. Lau, Capucine Penicaud, Teresa Pollicino, Barbara Testoni, Florian Van Bömmel, Ourania Andrisani, Maria Beumont-Mauviel, Timothy M. Block, Henry L. Y. Chan, Gavin A. Cloherty, William E. Delaney, Anna Maria Geretti, Adam Gehring, Kathy Jackson, Oliver Lenz, Mala K. Maini, Veronica Miller, Ulrike Protzer, Jenny C. Yang, Man-Fung Yuen, Fabien Zoulim, Peter A. Revill. A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook. Nature Reviews Gastroenterology & Hepatology 2022; 19(11): 727 doi: 10.1038/s41575-022-00649-z
|
| 33 |
Mayuko Nishi, Kei Miyakawa, Satoko Matsunaga, Hajera Khatun, Yutaro Yamaoka, Koichi Watashi, Masaya Sugiyama, Hirokazu Kimura, Takaji Wakita, Akihide Ryo. Prolyl Isomerase Pin1 Regulates the Stability of Hepatitis B Virus Core Protein. Frontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00026
|
| 34 |
Satender Pal Singh, Nitisha Mondia. Comment on the risk of hepatocellular carcinoma with chronic hepatitis B infection in Sweden. Hepatology Communications 2022; 6(12): 3592 doi: 10.1002/hep4.2046
|
| 35 |
|
| 36 |
Tung-Hung Su, Jia-Horng Kao. Unmet Needs in Clinical and Basic Hepatitis B Virus Research. The Journal of Infectious Diseases 2017; 216(suppl_8): S750 doi: 10.1093/infdis/jix382
|
| 37 |
Luca Rinaldi, Antonio Ascione, Vincenzo Messina, Valerio Rosato, Giovanna Valente, Vincenzo Sangiovanni, Rosa Zampino, Aldo Marrone, Luca Fontanella, Nicolina de Rosa, Pasquale Orabona, Carmela Buonomo, Antonio Chirianni, Luigi Elio Adinolfi, Guido Piai. Influence of antiviral therapy on the liver stiffness in chronic HBV hepatitis. Infection 2018; 46(2): 231 doi: 10.1007/s15010-017-1113-1
|
| 38 |
Bao-Min Shi, Wen Lu, Kun Ji, Yu-Feng Wang, Shuai Xiao, Xiu-Yan Wang. Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinoma. World Journal of Gastroenterology 2017; 23(20): 3713-3720 doi: 10.3748/wjg.v23.i20.3713
|
| 39 |
Tony Stankus. Reviews of Science for Science Librarians: Low-FODMAP Diets for Irritable Bowel Syndrome and Related Disorders. Science & Technology Libraries 2019; 38(3): 243 doi: 10.1080/0194262X.2019.1617226
|
| 40 |
Derek J. Erstad, Bryan C. Fuchs, Kenneth K. Tanabe. Molecular signatures in hepatocellular carcinoma: A step toward rationally designed cancer therapy. Cancer 2018; 124(15): 3084 doi: 10.1002/cncr.31257
|
| 41 |
Haneulsaem Shin, Yeon Woo Jung, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Yeun-Yoon Kim, Jin-Young Choi, Seung Up Kim. Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis B. Clinical and Molecular Hepatology 2019; 25(4): 390 doi: 10.3350/cmh.2018.0103
|
| 42 |
Jung Woo Shin, Joonho Jeong, Seok Won Jung, Seung Bum Lee, Bo Ryung Park, Min-Ju Kim, Eun Ji Park, Neung Hwa Park. Comparable Incidence of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir. Digestive Diseases and Sciences 2021; 66(5): 1739 doi: 10.1007/s10620-020-06375-3
|
| 43 |
Yeon Seok Seo, Byoung Kuk Jang, Soon Ho Um, Jae Seok Hwang, Kwang-Hyub Han, Sang Gyune Kim, Kwan Sik Lee, Seung Up Kim, Young Seok Kim, Jung Il Lee. Validation of risk prediction models for the development of HBV-related HCC: a retrospective multi-center 10-year follow-up cohort study. Oncotarget 2017; 8(68): 113213 doi: 10.18632/oncotarget.22375
|
| 44 |
Zejian (Eric) Wu, Da Xu, Paul Jen-Hwa Hu, Ting-Shuo Huang. A hierarchical multilabel graph attention network method to predict the deterioration paths of chronic hepatitis B patients. Journal of the American Medical Informatics Association 2023; 30(5): 846 doi: 10.1093/jamia/ocad008
|
| 45 |
Ching-Chung Lin, Ming-Jong Bair, Chia-Yuan Liu, Ze-Yu Lin, Chih-Jen Chen, Ming-Jen Chen, Cheng-Hsin Chu, Horng-Yuan Wang, Shou-Chuan Shih, Tsang-En Wang. High percentage atypical hepatocellular carcinoma in chronic hepatitis B patients treated with nucleos(t)ide analogs. Medicine 2019; 98(1): e13818 doi: 10.1097/MD.0000000000013818
|
| 46 |
Xiang Cui, Xiaoyan Jiang, Chunshan Wei, Yufeng Xing, Guangdong Tong. Astragaloside IV suppresses development of hepatocellular carcinoma by regulating miR-150-5p/β-catenin axis. Environmental Toxicology and Pharmacology 2020; 78: 103397 doi: 10.1016/j.etap.2020.103397
|